Review Articles

How close are we to incorporating measurable residual disease into clinical practice for acute myeloid leukemia?

Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
Vol. 104 No. 8 (2019): August, 2019 https://doi.org/10.3324/haematol.2018.208454